Comparing MTA versus Biodentine for complete pulpotomy in painful molars
Official title: Short Term Outcome of Complete Pulpotomy Using MTA vs Biodentine in Symptomatic Irreversible Pulpitis - A Randomized Controlled Trial
Run by Dow University of Health Sciences · NCT07483788 · Data updated 2026-11-12
This will test whether MTA or Biodentine works better to relieve pain and preserve the tooth in adults (18–40) with symptomatic irreversible pulpitis in a molar.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Dow University of Health Sciences Academic / other |
| Locations | 2 sites (Karachi, Sindh and 1 other locations) |
| Status | Recruiting |
| Started | November 2, 2024 |
| Main results expected | November 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07483788 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–40 with cariously exposed molars, moderate-to-severe pain (VAS 4–10), positive cold/EPT indicating symptomatic irreversible pulpitis, a periapical index of 1, and where hemostasis can be achieved within 10 minutes are ideal candidates.
✕Probably not a fit
Patients with traumatic injuries, non-restorable lesions, immature/open root apices, internal or external resorption, calcified canals, or those who cannot achieve hemostasis within 10 minutes are unlikely to benefit from this procedure.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–40 who present with moderate to severe pain from cariously exposed maxillary or mandibular molars and meet diagnostic tests for symptomatic irreversible pulpitis will be treated at Dow University of Health Sciences. Treatment is done by one dentist over two visits with local anesthesia and rubber-dam isolation; the coronal pulp is removed, bleeding controlled within 10 minutes, and then either MTA or Biodentine is placed. Pain will be recorded on a 1–10 scale and baseline tests include cold test, electric pulp testing, and a periapical radiograph; follow-up focuses on short-term clinical outcomes. The trial compares the two biomaterials' performance for complete pulpotomy in this specific patient group at a single center in Karachi.
Why it matters
Potential benefit: If successful, the finding could offer a reliable, less invasive option to quickly relieve pain while preserving the tooth's vitality.
How similar studies have gone: Previous clinical reports have shown promising short-term success using MTA for pulpotomy and emerging evidence suggests Biodentine often achieves similar outcomes, though follow-up durations vary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Teeth of generally healthy patients having following criteria will be included: 1. Age between 18-40 years of both males and females 2. Carious exposed maxillary and mandibular molars teeth 3. Moderate to severe pain (VAS 4-10) 4. Diagnosed with Symptomatic irreversible pulpitis on cold test and Electric pulp test (EPT) 5. Periapical index of 1 6. Hemostasis is achieved within 10 mins after full pulpotomy Exclusion Criteria: Teeth of generally healthy patients having following criteria will be excluded: 1. Any traumatic injury 2. Non-restorable carious lesion 3. Immature or Open apices of roots 4. Internal or external Resorption 5. Calcified canals
Where it's running
-
Dr Khadija Zubair
Karachi, Sindh, Pakistan Recruiting -
Dr Khadija Zubair
Karachi, Sindh, Pakistan Recruiting
Study contacts
- Principal investigator: Dr Khadija Zubair, Postgraduate Trainee- FCPS — Dow University of Health Sciences
- Study coordinator: Dr Khadija Zubair, Postgraduate trainee- FCPS
- Email: khadija.zubair21@yahoo.com
- Phone: 03363605145
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pain relief after a single-visit root canal: comparing acetaminophen, NSAIDs, and trypsin-chymotrypsin combo
This trial tests whether acetaminophen alone, an NSAID, or a combination of trypsin-chymotrypsin with acetaminophen best relieves pain after a single-visit root canal in adults with symptomatic irreversible pulpitis.
-
Partial pulpotomy in mature lower molars with SIP using calcium hypochlorite vs sodium hypochlorite
This trial tests whether washing the exposed pulp with calcium hypochlorite or with sodium hypochlorite during partial pulpotomy in adults helps healing and reduces pain.
-
Local dexamethasone to improve anesthesia in painful irreversible pulpitis
This trial tests whether giving dexamethasone under the gum or between tooth-supporting ligaments helps make anesthetic blocks work better and reduce pain in adults with painful irreversible pulpitis in the lower molars.
-
Using intraoral cold to improve numbness in lower front teeth
This trial will see if applying cold inside the mouth helps buccal infiltration anesthesia work better for adults with symptomatic irreversible pulpitis in a lower front tooth.
-
Intraligamentary injection versus inferior alveolar nerve block for painful lower molar pulpitis
This trial will see if an intraligamentary injection or an inferior alveolar nerve block gives better pain control for adults having root canal treatment of a painful lower molar with symptomatic irreversible pulpitis.
-
Cryotherapeutic and Nanotherapeutic Sodium Hypochlorite for Post-Operative Endodontic Pain
This trial tests whether cooling or nano-enhanced sodium hypochlorite as the final root canal irrigant can reduce pain after treatment in adults with certain tooth infections.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.